---

Market Overview

---

The global radiation dose management market experienced a valuation of $213 million in 2021 and is projected to reach $587 million by 2032. This growth, with a compound annual growth rate (CAGR) of 10.30% during the forecast period 2022-2032, will be fueled by several factors. These include the increasing prevalence of chronic disorders necessitating diagnostic intervention, the growing emphasis on interventional radiology (IR), and the rising awareness surrounding patient safety and the detrimental effects of excessive exposure to ionizing radiation.

Although the utilization of medical imaging techniques has seen a decline in radiation exposure due to technological advancements like dose-lowering technologies, concerns about the harmful effects of radiation exposure persist. The demand for non-invasive imaging modalities for diagnostic examinations has been rising globally, driven by the increasing prevalence of chronic diseases requiring diagnostic intervention. In the United States, medical imaging procedures contribute to nearly half of an individual’s overall radiation exposure. Overexposure to radiation can result in adverse effects such as skin reddening, hair loss, and even long-term cancer development.

Imaging modalities that emit ionizing radiation include computed tomography (CT), X-ray, angiography systems, mammography systems, fluoroscopy systems, and nuclear imaging systems. According to the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), during the period of 2009-2018, CT accounted for approximately 9.60% of examinations conducted using these modalities, yet it contributed significantly to the effective dose received at nearly 62.00%. As a result, many governments have established regulatory guidelines, known as diagnostic reference levels (DRLs), to regulate the effective dose received by patients during examinations. These DRLs serve as benchmarks for healthcare providers in hospitals, clinics, and imaging facilities, aiding in the optimization of radiation doses. Real-time dose optimization can be achieved by modifying parameters such as patient positioning.

The radiation dose management market is currently in the developmental stage. The development of on-cloud dose management solutions and the increasing focus on radiation dose management for pediatric procedures present significant opportunities. Additionally, key market trends include the development of imaging modalities with reduced radiation dose technologies, partnerships and strategic alliances dominating the market, and collaborations among market players.

The COVID-19 pandemic led to a decline in imaging volumes, impacting the utilization of radiation diagnostic equipment. Strict protocols regarding disinfection using ethanol were implemented to minimize the risk of COVID-19 transmission.

In the post-pandemic scenario, imaging volumes are expected to gradually return to pre-pandemic levels. As the severity of the COVID-19 pandemic decreases, hospitals are predicted to allocate more resources to radiology and pursue diagnostic imaging with renewed vigor. In the long term, radiology practices may be permanently redesigned as radiologists become more comfortable treating patients remotely. Furthermore, hospitals and healthcare institutions are expected to enhance their preparedness to handle unprecedented events that may disrupt their operations.

The COVID-19 pandemic highlighted the importance of automating tasks that previously required manual intervention. Advanced dose management software (DMS) facilitates automated data transfer from imaging systems into the DMS, as well as automated dose recording. This automation helps eliminate human errors and reduces the need for human intervention, a concept that gained momentum during the pandemic.

---

Market Segmentation

---

The market is segmented based on various factors, including modality, product, mode of deployment, end user, and region.

Segmentation by Modality
CT Scanners
X-Ray, CR, and DR
Mammography Systems
Interventional Angiography Systems/Angio CT
Fluoroscopy Systems
PET Scanners and SPECT
Hybrid Imaging

Segmentation by Product
Radimetrics Enterprise Platform
DoseWatch and DoseWatch Explore
teamplay Dose
NEXO [DOSE]
tqm/Dose and DoseMonitor
Radiation Dose Monitor
Imalogix Platform
Syncro-Dose
NovaDose
DoseWise Portal
SafeCT
MyXrayDose
DoseM
Dose Tracking System
DoseTrack

Segmentation by Mode of Deployment
Web-Based
On-Premise
Cloud-Based

Segmentation by End User
Hospitals
Diagnostic Centers
Others

Segmentation by Region
North America – U.S. and Canada
Europe – Germany, France, U.K., Italy, Spain, Netherlands, and Rest-of-Europe
Asia-Pacific – Japan, China, India, Australia and New Zealand, South Korea, and Rest-of-Asia-Pacific
Latin America – Brazil, Mexico, and Rest-of-Latin America
Middle East and Africa

The largest share in the global radiation dose management market is currently held by CT scanners. This is due to their easy availability, lower imaging cost, and ability to provide quick diagnoses, leading to higher adoption rates. CT scanners are three-dimensional medical imaging procedures that use X-rays to create images of blood vessels, internal organs, and bones. They are widely available and non-invasive diagnostic tools used to diagnose various disorders, plan and guide therapeutic procedures, and monitor the effectiveness of therapy.

In terms of products, the Radimetrics Enterprise Platform by Bayer AG dominates the global radiation dose management market, followed by DoseWatch. The Radimetrics Enterprise Platform is an integrated solution for managing radiation and contrast doses. It can be seamlessly integrated with radiology workflows and hospital IT infrastructure to track examination doses across patients. This platform helps hospitals meet compliance requirements, enhance workflow efficiency, and ensure patient safety.

The web-based segment dominates the mode of deployment in the global radiation dose management market. It is expected to generate the highest incremental opportunity of $182 million from 2022 to 2032. Web-based radiation dose management software offers tools for capturing radiation data quickly and effectively. It can be securely accessed from any computer with an internet connection, allowing customers to receive and access data without requiring administrator permission. Web-based applications are attractive to healthcare organizations like hospitals and diagnostic centers due to their low maintenance requirements and minimal IT infrastructure. The growth of this segment is driven by factors such as increased flexibility, scalability, and low maintenance costs. However, the need for an internet connection poses a constraint on its growth. Market players like Bayer AG, Bracco, General Electric Company, Infinitt Healthcare Co. Ltd., MyXrayDose Ltd, NovaRad Corporation, and Koninklijke Philips N.V. offer web-based dose management solutions.

Hospitals dominate the end-user segment of the global radiation dose management market. They are expected to create the highest incremental opportunity of $203 million from 2022 to 2032, followed by diagnostic centers at $103 million. Hospitals accounted for the largest market share in 2021 and are projected to maintain this trend throughout the forecast period. Most hospitals have dedicated radiology departments for medical imaging, and operating rooms (ORs) are major sources of income for large hospitals. The integration of imaging systems in hybrid operating rooms is a significant driver for the adoption of dose management software.

In terms of regional distribution, North America held the largest market share of 43.71% in 2022, followed by Europe at 24.45%. Asia-Pacific is expected to experience significant growth, with a high compound annual growth rate (CAGR) of 11.83% during the forecast period from 2022 to 2032.

---

Competitive Landscape

---

The selection of the featured companies was based on inputs gathered from primary experts, as well as an analysis of their company coverage, product portfolio, and market penetration.

Key companies profiled in this report include Agfa-Gevaert Group, Bracco, Bayer AG, Canon Inc., FUJIFILM Holdings Corporation, Guerbet, General Electric Company, Imalogix, Infinitt Healthcare Co., Ltd., Koninklijke Philips N.V., LANDAUER, Medic Vision Imaging Solutions Ltd., Medsquare, MyXrayDose Ltd., Novarad Corporation, PACSHealth, LLC, Qaelum NV, Sectra AB, SST Group Inc., Siemens Healthineers AG, Virtual Phantoms Inc.

---

Recent Industry Developments

---

In December 2020, Bayer AG introduced Radimetrics v3.0, which represents the latest iteration of its enterprise dose management utility.

In December 2020, FUJIFILM Holdings Corporation unveiled SYNAPSE Dose 2.0, a unique system designed to provide comprehensive management of patient radiation exposure across multiple imaging modalities.

In January 2020, Agfa HealthCare collaborated with Maasstad Hospital in the Netherlands to support advancements in the consistency and optimization of radiation doses.

In April 2019, Qaelum NV entered into an agreement with TOYO Corporation to distribute its dose monitoring solution, DOSE, in Japan.

In January 2019, SST Group, Inc. partnered with Intermountain Healthcare to implement a software platform called the Radiation Dose Monitor (RDM). This platform enables medical professionals to effectively manage, analyze, and optimize the dose delivered to patients during interventional procedures, medical imaging examinations, and image-guided surgeries.

In August 2018, Imalogix launched an enhanced version of its radiation dose management platform, featuring additional capabilities in the field of fluoroscopy. This software solution is capable of automatically calculating the peak skin dose for patients undergoing fluoroscopic procedures.

In August 2018, Guerbet LLC USA, a subsidiary of the Guerbet Group, entered into a partnership with Imalogix. The collaboration focused on reducing inconsistencies and advancing the quality, safety, and efficiency of care related to radiation dose management, allowing network health systems and member facilities to monitor patient radiation dose on a per-procedure and cumulative basis.

In March 2018, PACSHealth, LLC introduced DoseMonitor, a software solution for radiation dose management that enables accurate tracking of radiation dose absorption.

---

Key Questions Answered

---

What are the primary drivers, challenges, and opportunities in the global market for radiation dose management?

What emerging trends can be observed in the global radiation dose management market?

What is the growth potential of the radiation dose management market in North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa?

What is the trend of patent filings in the global radiation dose management market?

What are the average prices of radiation dose management software, and how do they compare to manual dose recording methods?

Can you provide some case studies from the global radiation dose management market?

How is the market segmented based on modality in the radiation dose management industry?

How are modalities ranked in terms of the level of software integration being implemented with each of them?

How has the COVID-19 pandemic affected the global radiation dose management market?
What are the existing gaps in the market, and how can market players leverage these opportunities?

Can you provide information on the key features, compatible modalities, and installed base of 15 dose management software solutions in the global radiation dose management market?